Gonadorelin vs Oxandrolone
A side-by-side research comparison of Gonadorelin and Oxandrolone across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Gonadorelin | Oxandrolone |
|---|---|---|
| Full name | Gonadorelin (GnRH Analog) | Oxandrolone (Anavar) |
| Category | Hormone Replacement | Hormone Replacement |
| Status | FDA Approved | FDA Approved (Schedule III) |
| Mechanism | Binds GnRH receptors on pituitary gonadotrophs to stimulate LH and FSH release, maintaining testicular/ovarian function and natural sex hormone production. | Binds androgen receptors with high anabolic:androgenic ratio (~10:1). Does not aromatize to estrogen. Increases nitrogen retention, protein synthesis, and phosphocreatine resynthesis while reducing SHBG. |
| Molecular weight | 1182.39 Da | 306.44 Da |
| Half-life | ~10-40 minutes | ~9 hours |
| Bioavailability | ~90% subcutaneous | ~97% oral |
| Typical dose | 100-500 mcg | 10-20 mg (therapeutic); 20-50 mg (performance) |
| Frequency | 2-3x per week or pulsatile | Split 2x daily |
| Route | Subcutaneous injection | Oral |
Gonadorelin reported benefits
- Maintains natural hormone production
- Fertility preservation
- Testicular function support
- LH/FSH normalization
Oxandrolone reported benefits
- Lean muscle gain without water retention
- Increased strength
- Fat loss (visceral)
- Wound healing acceleration
- Minimal estrogenic effects
- Improved bone density
Related comparisons
Research and educational reference only. Not medical advice.